Bayer bets on 'silver bullet' defense in Roundup litigation; experts see hurdles
Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be tossed because a U.S. regulatory agency said the herbicide is not a public health risk.
from Reuters: Health News https://reut.rs/2Jqf7Ce
http://bit.ly/2zwRqiM
May 16, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on May 16, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.